SNDX Syndax Pharmaceuticals
- 18.270
- -0.360-1.93%
- 18.240
- -0.030-0.16%
Syndax Pharmaceuticals News
Citi Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Raises Target Price to $34
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $31 to $45
Syndax Pharmaceuticals Analyst Ratings
Barclays Maintains Overweight on Syndax Pharmaceuticals, Raises Price Target to $33
Buy Rating Affirmed for Syndax Pharmaceuticals Amid Niktimvo's Promising Market Entry and Efficacy
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $31 to $35
Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), Arrowhead Pharmaceuticals (ARWR) and Syndax Pharmaceuticals (SNDX)
Analysts Are Bullish on Top Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Medtronic (MDT)
Barclays Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)
Syndax Pharmaceuticals Analyst Ratings
Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $32
Barclays Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)
Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $40
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $23 to $41
Syndax Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Denali Therapeutics (DNLI) and Bio-Rad Laboratories (BIO)
Buy Rating Affirmed on Syndax Pharmaceuticals Amid Strong Trial Results and Solid Financial Position
Strong Buy Rating for Syndax Pharmaceuticals Amid Positive Drug Approval Prospects
Scotiabank Maintains Syndax Pharmaceuticals(SNDX.US) With Hold Rating, Maintains Target Price $23
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $23 to $41
Analysis
Price Target
No Data
No Data